UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY)

Q: What does CUSIP 90466Y103 represent in this 13F holders report?

CUSIP 90466Y103 is the security identifier for UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in Q1 2024?

21 institutional investors reported UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share for Q1 2024. Use the holders table for investor-level position and value details.

CUSIP: 90466Y103

Q1 2024 13F Holders as of 31 Mar 2024

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 14,441,576
Total 13F value: $19,929,234
Share change: +4,849,086
SEC-reported price per share: $1.38
Number of holders: 21
Value change: +$6,691,650
Number of buys: 14
Number of sells: 1
Shares outstanding: 18,578,488

Security key

90466Y103

Report period

Q1 2024

Institutions

Top holders

UNCY full security history Ownership snapshot Full 13F holder table Unicycive Therapeutics, Inc. SEC filings Unicycive Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

RA CAPITAL MANAGEMENT, L.P.

Disclosed value leader

RA CAPITAL MANAGEMENT, L.P.

Comparable rows

15/15

Latest evidence

31 Dec 2023

13F Lead comparable stake: 19% Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 19%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.

Comparable ownership Top 5

RA CAPITAL MANAGEMENT, L.P. 19%

Vivo Capital, LLC 19%

Nantahala Capital Management, LLC 19%

BVF INC/IL 11%

GEODE CAPITAL MANAGEMENT, LLC 0.91%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
RA CAPITAL MANAGEMENT, L.P.	13F Company 13F	19%	$3,011,516 3,470,688 shares	—	31 Dec 2023
Vivo Capital, LLC	13F Company 13F	19%	$3,011,051 3,470,152 shares	—	31 Dec 2023
Nantahala Capital Management, LLC	13F Company 13F	19%	$2,983,309 3,438,181 shares	—	31 Dec 2023
BVF INC/IL	13F Company 13F	11%	$1,837,909 2,118,139 shares	—	31 Dec 2023
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	0.91%	$146,755 169,132 shares	—	31 Dec 2023
VANGUARD GROUP INC	13F Company 13F	0.62%	$99,835 115,057 shares	—	31 Dec 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

14,441,576

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders

Holder diff

Investor	Q1 2024 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q1 2024 value	Q1 2024 value	Value change	Value Chg %